A Phase 1 Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

Trial Profile

A Phase 1 Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs E 6130 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Adverse reactions
  • Sponsors EA Pharma
  • Most Recent Events

    • 02 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 20 Feb 2017 Planned End Date changed from 1 Mar 2018 to 1 Sep 2017.
    • 27 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top